Isolation of intertypic recombinants of Epstein-Barr virus from T- cell-immunocompromised individuals

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4895-4903

  Yao, Q Y ^a   Tierney, R J ^a   Croom Carter, D ^a   Cooper, G M ^b   Ellis, C J ^b   Rowe, M ^a   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 0029900310     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4895-4903.1996     Document Type: Article

References (53)

1. Abdel-Hamid, M., J. J. Chen. N. Constantine, M. Massoud, and N. Raab-Traub. 1992. EBV strain variation: geographical distribution and relation to disease state. Virology 190:168-175.
2. Adldinger, H. K., H. Delius, U. K. Freese, J. Clarke, and G. W. Bornkamm. 1985. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221-234.
3. Aitken, C., S. K. Sengupta, C. Aedes, D. J. Moss, and T. B. Sculley. 1994. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J. Gen. Virol. 75:95-100.
4. Anagnostopoulus, I., M. Hummel, C. Kreschel, and H. Stein. 1995. Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744-750.
5. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. G. Gibson, G. Hatful, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnel, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207-211.
6. Boyle, M. J., W. A. Sewell, T. B. Sculley, A. Apolloni, J. J. Turner, C. E. Swanson, R. Penny, and D. A. Cooper. 1991. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphomas. Blood 78:3004-3011.
7. Burrows, J. M., R. Khanna, T. B. Sculley, M. P. Alpers, D. J. Moss, and S. R. Burrows. 1996. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70:4829-4833.
8. Busson, P., R. McCoy, R. Sadler, K. Gilligan, T. Tursz, and N. Raab-Traub. 1992. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol. 66:3257-3262.
9. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
10. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81:7632-7636.
11. De Re, V., M. Buiocchi, S. De Vita, R. Dolcetti, A. Gloghini, S. Uccini, C. Baroni, A. Sarpa, G. Cattoretti, and A. Carbone. 1993. Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. Int. J. Cancer 54:895-898.
12. Diaz-Mitoma, F., A. Ruiz, G. Flowerdew, S. Houston, B. Romanowski, T. Kovithavongs, J. Preiksatis, and D. L. Tyrrell. 1990. High levels of Epstein-Barr virus in the oropharynx: a predictor of disease progression in human immunodeficiency virus infection. J. Med. Virol. 31:69-75.
13. Falk, K., J. W. Gratama, M. Rowe, J. Z. Zou, F. Khanim, L. S. Young, M. A. P. Oosterveer, and I. Ernberg. 1995. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR anal-ysis. J. Gen. Virol. 76:779-790.
14. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosen, J. Dillner, and G. Klein. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen (EBNA5) detect multiple protein species in Burkitt lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870-3878.
15. Gralama, J. W., E. T. Lennette, B. Lonnqvist, M. A. P. Oosterveer, G. Klein, O. Ringden, and I. Ernberg. 1992. Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J. Med. Virol. 37: 39-47.
16. Gratama, J. W., M. A. P. Oosterveer, W. Weimar, K. Sintnicolaas, W. Sizoo, R. L. H. Bolhuis, and I. Ernberg. 1994. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J. Gen. Virol. 75: 85-94.
17. Greenspan, J. S., D. Greenspan, E. T. Lennette, D. I. Abrams, M. A. Conant, V. Petersen, and U.K. Freese. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313:1564-1571.
18. K recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568-7572.
19. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalising functions of Epstein-Barr virus in human B lymphocytes. Nature (London) 340:393-397.
20. K. Science 265:92-95.
21. Khanim, F., Q. Y. Yao, G. Niedobitek, S. Sihota, A. B. Rickinson, and L. S. Young. Analysis of Epstein-Barr virus gene polymorphisms in geographically distinct virus isolates of normal donor and tumour origin. Submitted for publication.
22. Kremmer, E., B. R. Kranz, A. Hille, K. Klein, M. Eulitz, G. Hoffmann-Fezer, W. Feiden, K. Herrmann, H.-J. Delecluse, G. Delsol, G. W. Bornkamm, N. Muller-Lantzsch, and F. A. Grasser. 1995. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 208:336-342.
23. Kunimoto, M., S. Tamura, T. Tabata, and O. Yoshie. 1992. One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J. Gen. Virol. 73:455-461.
24. Kyaw, M. T., L. Hurren, L. Evans, D. J. Moss, D. A. Cooper, E. Benson, E. Esmore, and T. B. Sculley. 1992. Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res. Hum. Retroviruses 8:1869-1874.
25. Lees, J. F., J. E. Arrand, S. D. Pepper, J. P. Stewart, M. Mackett, and J. R. Arrand. 1993. The Epstein-Barr virus candidate antigen gp340/220 is highly conserved between virus type A and type B. Virology 195:578-586.
26. Marshall, D., and C. Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
27. Miller, W. E., R. H. Edwards, D. M. Walling, and N. Raab-Traub. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75:2729-2740.
28. Packham, G., M. Brimmell, D. Cook, A. J. Sinclair, and P. J. Farrell. 1993. Strain variation in Epstein-Barr virus immediate early genes. Virology 192: 541-550.
29. Rabson, M., L. Gradoville, L. Heston, and G. Miller. 1982. Nonimmortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol. 44:834-844.
30. Rickinson, A. B. Unpublished data.
31. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia.
32. Rickinson, A. B., L. S. Young, and M. Rowe. 1987. Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310-1317.
33. K. J. Virol. 69:3108-3116.
34. Rowe, M., L. S. Young, K. Cadwallader, L. Petti, E. Kieff, and A. B. Rickinson. 1989. Distinction between Epstein-Barr virus type A (EBNA2A) and type B (EBNA2B) isolates extends to the EBNA3 family of nuclear proteins. J. Virol. 63:1031-1039.
35. Rymo, L., T. Lindahl, S. Povey, and G. Klein. 1981. Analysis of restriction endonuclease fragments of intraceliular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC37 and F-265 human lymphoid cell lines. Virology 115:115-124.
36. Sample, J., E. F. Kieff, and E. D. Kieff. 1994. Epstein-Barr virus types 1 and 2 have nearly identical LMP1 transforming genes. J. Gen. Virol. 75:2741-2746.
37. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus types 1 (EBV-1) and 2 (EBV-2) differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:4084-4092.
38. Schuster, V., G. Ott, S. Seidenspinner, and H. W. Kreth. 1996. Common Epstein-Barr virus (EBV) type 1 variant strains in both malignant and benign EBV-associated disorders. Blood 87:1579-1585.
39. Sculley, T. B., A. Apolloni, D. J. Moss, N. Muller-Lantsch, I. S. Misko, and D. A. Cooper. 1989. Expression of Epstein-Barr virus nuclear antigens 3, 4 and 6 are altered in cell lines containing B type virus. Virology 171:401-408.
40. Sixbey, J. W., P. Shirley, P. J. Chesney, D. M. Buntin, and L. Resnick. 1989 Detection of a second widespread strain of Epstein-Barr virus. Lancet ii: 761-765.
41. Sixbey, J. W., P. Shirley, M. Sloas, N. Raab-Traub, and V. Israele. 1991. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replieative infection. J. Infect. Dis. 163:1008-1015.
42. Skare, J., J. Farley, J. L. Strominger, K. O. Fresen, M. S. Cho, and H. zur Hausen. 1985. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J. Virol. 55:286-297.
43. Stuart, A. D., J. P. Stewart, J. R. Arrand, and M. Mackett. 1995. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11:1711-1719.
44. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins (EBNA) 3A and 3C are essential for B lymphocyte growth transformation. J. Virol. 67:2014-2025.
45. Walling, D. M., N. M. Clark, D. M. Markovitz, T. S. Frank, D. K. Brawn, E. Eisenberg, D. J. Krutchkoff, D. H. Felix, and N. Raab-Traub. 1995. Epstein-Barr virus co-infection and recombination in non-human-immunodeficiency virus-associated oral hairy leutoplakia. J. Infect. Dis. 171:1122-1130.
46. Walling, D. M., S. N. Edmistan, J. W. Sixbey, M. Abdel-Hamid, L. Resnick, and N. Raab-Traub. 1992. Co-infection of multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc. Natl. Acad. Sci. USA 89:6560-6564.
47. Walling, D. M., A. G. Perkins, J. Websler-Cyriaque, L. Resnick, and N. Raab-Traub. 1994. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J. Virol. 68:7918-7926.
48. Walling, D. M., and N. Raab-Traub. 1994. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J. Virol. 68:7909-7917.
49. Wrightham, M. N., J. P. Stewart, N. J. Janjua, S. D. V. Pepper, C. Sample, C. M. Rooney, and J. R. Arrand. 1995. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208:521-530.
50. Yao, Q. Y., M. Rowe, B. Martin, L. S. Young, and A. B. Rickinson. 1991. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J. Gen. Virol. 72:1579-15911.
51. Yao, Q. Y., R. J. Tierney, D. Croom-Carter, D. Dukers, G. M. Cooper, C. J. Ellis, M. Rowe, and A. B. Rickinson. 1996. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J. Virol. 70:4884-4894.
52. Young, L. S., Q. Y. Yao, C. M. Rooney, T. B. Sculley, D. J. Moss, H. Rupani, G. Laux, G. W. Bornkamm, and A. B. Rickinson. 1987. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol. 68:2853-2862.
53. Zimber, U., H. K. Adldinger, G. M. Lenoir, M. Vuillaume, M. V. Knebel-Doeberitz, G. Laux, C. Desgranges, P. Wittman, U. K. Freese, U. Schneider, and G. W. Bornkamm. 1986. Geographic prevalence of two Epstein-Barr virus types. Virology 154:56-66.